Markets:

Overview

News

Currencies

International

Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

23.43 +0.46 (+2.00%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Fulgent Genetics: Q1 Earnings Insights ↗

May 05, 2023

Via Benzinga

Earnings Scheduled For May 5, 2023 ↗

May 05, 2023

Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion.

Via Benzinga

Preview: Fulgent Genetics's Earnings ↗

May 04, 2023

Via Benzinga

Looking Into Fulgent Genetics's Return On Capital Employed ↗

March 06, 2023

Via Benzinga

Where Fulgent Genetics Stands With Analysts ↗

December 08, 2022

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

December 05, 2022

Via Benzinga

7 Stocks to Buy to Bag Big-Time Returns in Q2 ↗

April 16, 2023

If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

January 06, 2023

During Friday's trading, 71 companies set new 52-week lows.

Via Benzinga

Fulgent Genetics's Return on Invested Capital Insights ↗

December 01, 2022

Via Benzinga

1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings ↗

November 24, 2022

Strong core business growth was overshadowed in Q3 by an acquisition.

Via The Motley Fool

4 Analysts Have This to Say About Fulgent Genetics ↗

November 18, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Why Fulgent Genetics Shares Are Trading Higher Today ↗

April 19, 2022

Via Benzinga

Which Is the Better Buy: Vertex or Invitae? ↗

December 16, 2022

Is Vertex worth its lofty valuation compared to Invitae?

Via The Motley Fool

My Top 7 Strong Conviction Buys for 2023 ↗

December 15, 2022

Companies that are down on their luck this year are in strong contention for conviction buys for 2023 as they rebound.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022 ↗

November 18, 2022

Upgrades

Via Benzinga

Earnings Preview: Fulgent Genetics ↗

November 04, 2022

Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Fulgent...

Via Benzinga

Recap: Fulgent Genetics Q4 Earnings ↗

February 23, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

October 24, 2022

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

October 03, 2022

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Fulgent Genetics's Return On Invested Capital Insights ↗

August 22, 2022

Pulled from Benzinga Pro data, Fulgent Genetics (NASDAQ:FLGT) posted Q2 earnings of $11.10 million, an increase from Q1 of 92.77%. Sales dropped to $125.34 million, a 60.86% decrease between quarters.

Via Benzinga

Recap: Fulgent Genetics Q2 Earnings ↗

August 04, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat...

Via Benzinga

Fulgent Genetics: Q1 Earnings Insights ↗

May 03, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated...

Via Benzinga

Earnings Outlook For Fulgent Genetics ↗

May 02, 2022

Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Fulgent...

Via Benzinga

These Are Ten Small Cap Stocks With Strong Buy Recommendations ↗

March 27, 2022

One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks...

Via Talk Markets

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 03, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

Headline News about Fulgent Genetics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today